Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Duong

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMC Public Health|March 7, 2025
"Sometimes I'm interested in seeing a fuller story to tell with numbers" Implementing a forecasting dashboard for harm reduction and overdose prevention: a qualitative assessmentJesse Yedinak Gray, Maxwell Krieger, Alexandra Skinner, et al.
JMIR Mhealth and Uhealth|January 12, 2024
SOMAScience: A Novel Platform for Multidimensional, Longitudinal Pain AssessmentChloe Zimmerman Gunsilius, Joseph Heffner, Sienna Bruinsma, et al.
Nature Cancer|January 17, 2025
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Nature Cancer|December 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapiesEmi A Lutz, Yash Agarwal, Noor Momin, et al.
Journal of Public Health Management and Practice : JPHMP|August 27, 2024
Project SIGNAL: A Dashboard for Supporting Community Confidence in Making Data-Driven DecisionsMaxwell Krieger, Sam Bessey, Salma Abadin, et al.
Plos One|September 24, 2020
ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical modelsAmanda Hanson, Kutlu Elpek, Ellen Duong, et al.
Journal of Medical Internet Research|February 12, 2024
Public Health Dashboards in Overdose Prevention: The Rhode Island Approach to Public Health Data Literacy, Partnerships, and ActionJesse Yedinak, Maxwell S Krieger, Raynald Joseph, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation statesGiovanni Galletti, Anna-Maria Globig, Olga Barreiro, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response ProteinsSasha Friese, Junjie Zai, Grace Luzbetak, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Public Health|March 7, 2025
"Sometimes I'm interested in seeing a fuller story to tell with numbers" Implementing a forecasting dashboard for harm reduction and overdose prevention: a qualitative assessmentJesse Yedinak Gray, Maxwell Krieger, Alexandra Skinner, et al.
JMIR Mhealth and Uhealth|January 12, 2024
SOMAScience: A Novel Platform for Multidimensional, Longitudinal Pain AssessmentChloe Zimmerman Gunsilius, Joseph Heffner, Sienna Bruinsma, et al.
Nature Cancer|January 17, 2025
Publisher Correction: TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Nature Cancer|December 16, 2024
TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulationKatherine Nutsch, Karl L Banta, Thomas D Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapiesEmi A Lutz, Yash Agarwal, Noor Momin, et al.
Journal of Public Health Management and Practice : JPHMP|August 27, 2024
Project SIGNAL: A Dashboard for Supporting Community Confidence in Making Data-Driven DecisionsMaxwell Krieger, Sam Bessey, Salma Abadin, et al.
Plos One|September 24, 2020
ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical modelsAmanda Hanson, Kutlu Elpek, Ellen Duong, et al.
Journal of Medical Internet Research|February 12, 2024
Public Health Dashboards in Overdose Prevention: The Rhode Island Approach to Public Health Data Literacy, Partnerships, and ActionJesse Yedinak, Maxwell S Krieger, Raynald Joseph, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation statesGiovanni Galletti, Anna-Maria Globig, Olga Barreiro, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response ProteinsSasha Friese, Junjie Zai, Grace Luzbetak, et al.
Pageof 3